Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046125
Filing Date
2025-03-27
Accepted
2025-03-27 16:30:13
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K spro-20241231.htm   iXBRL 10-K 3652969
2 EX-10.4 spro-ex10_4.htm EX-10.4 164860
3 EX-10.8 spro-ex10_8.htm EX-10.8 39051
4 EX-10.12 spro-ex10_12.htm EX-10.12 40428
5 EX-10.19 spro-ex10_19.htm EX-10.19 42130
6 EX-10.22 spro-ex10_22.htm EX-10.22 40920
7 EX-10.25 spro-ex10_25.htm EX-10.25 66324
8 EX-10.26 spro-ex10_26.htm EX-10.26 125898
9 EX-10.28 spro-ex10_28.htm EX-10.28 133718
10 EX-10.42 spro-ex10_42.htm EX-10.42 25320
11 EX-10.43 spro-ex10_43.htm EX-10.43 27276
12 EX-19.1 spro-ex19_1.htm EX-19.1 81226
13 EX-23.1 spro-ex23_1.htm EX-23.1 2650
14 EX-31.1 spro-ex31_1.htm EX-31.1 11384
15 EX-31.2 spro-ex31_2.htm EX-31.2 12829
16 EX-32 spro-ex32.htm EX-32 11890
17 EX-97.1 spro-ex97_1.htm EX-97.1 51146
18 GRAPHIC img36737646_0.jpg GRAPHIC 46934
19 GRAPHIC img43202293_0.jpg GRAPHIC 46934
20 GRAPHIC img65366797_0.jpg GRAPHIC 46934
21 GRAPHIC img68137360_0.jpg GRAPHIC 46934
22 GRAPHIC img163015762_0.jpg GRAPHIC 115236
23 GRAPHIC img163015762_1.jpg GRAPHIC 188390
24 GRAPHIC img163015762_2.jpg GRAPHIC 31128
25 GRAPHIC img196655433_0.jpg GRAPHIC 46934
  Complete submission text file 0000950170-25-046125.txt   15563481

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT spro-20241231.xsd EX-101.SCH 1961938
116 EXTRACTED XBRL INSTANCE DOCUMENT spro-20241231_htm.xml XML 2161511
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38266 | Film No.: 25779816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)